abstract |
The invention relates to the use of ambroxol and the pharmaceutically acceptable salts thereof for producing a drug for the treatment of diseases that are caused by a strong activation of voltage-gated sodium channels, especially for the treatment of chronic pains, cerebral excitotoxicity-related disorders and cardiac arrhythmias. |